?
Basho Chandan
COO and CFO
Apollo Medical Holdings, Inc.
US, Alhambra [HQ]
CIK
1929126
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
166,276
Price per Share :
$40.82
Equivalence :
$6,787,386.32
Transaction History
-
F166,276 Shares After TransactionValue : $6,981,929.24$273,228.93Transaction Date : 03/29/24
-
Footnotes
-
-
Footnotes:#1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 29, 2024 and April 14, 2024, respectively.#2 Total holdings includes 15,692 restricted stock units that were granted on April 2, 2024, as previously disclosed in a Form 4 filed on April 4, 2024.#3 Includes 84,356 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; and (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).
-
F158,283 Shares After TransactionValue : $6,445,283.76$325,474.96Transaction Date : 04/14/24
-
Footnotes
-
-
Footnotes:#1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 29, 2024 and April 14, 2024, respectively.#2 Total holdings includes 15,692 restricted stock units that were granted on April 2, 2024, as previously disclosed in a Form 4 filed on April 4, 2024.#3 Includes 84,356 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; and (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).
-
A172,783 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/02/24
-
Footnotes
-
-
Footnotes:#1 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 2, 2024 (the six month anniversary of the grant date).#2 Includes 152,372 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).
-
F151,232 Shares After TransactionValue : $6,220,172.16$290,007.63Transaction Date : 05/16/24
-
Footnotes
-
-
Footnotes:#1 Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.#2 Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which vest on May 16, 2025; and (iii) 45,606 shares, which vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).
-
A166,742 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/08/24
-
Footnotes
-
-
Footnotes:#1 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal installments, with the first installment vesting on November 8, 2024, and the remaining shares vesting in seven equal semi-annual installments beginning on April 2, 2025.#2 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on November 8, 2024.#3 Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which will vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 27,303 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025 (subject to continuous employment with the Issuer).